Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1350 of 3173 entries
View as:

A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00853112 Org: User:
Start: 04/30/09 End: 07/31/10 Due: 07/31/11

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01511497 Org: User:
Start: 10/31/11 End: 01/31/13 Due: 01/31/14

Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01208233 Org: User:
Start: 12/31/10 End: 12/31/13 Due: 12/31/14

Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

Phase: N/A Priority: Normal
NCT ID: NCT01646385 Org: User:
Start: 02/29/12 End: 08/31/12 Due: 08/31/13

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Phase: N/A Priority: Normal
NCT ID: NCT00818441 Org: User:
Start: 03/11/09 End: 04/30/15 Due: 04/30/16

Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia

Phase: N/A Priority: Normal
NCT ID: NCT00944970 Org: User:
Start: 10/31/05 End: 12/31/06 Due: 12/31/07

Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012

Phase: N/A Priority: Normal
NCT ID: NCT01056263 Org: User:
Start: 04/30/10 End: 12/31/10 Due: 12/31/11

The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02282059 Org: User:
Start: 12/12/14 End: 12/12/22 Due: 12/12/23

Analgesic Efficacy and Safety Study of T-62 in Subjects With Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT00809679 Org: User:
Start: 12/31/08 End: 06/30/09 Due: 06/30/10

To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04531083 In Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00992316 Org: User:
Start: 08/31/09 End: 12/31/09 Due: 12/31/10

A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01639001 Org: User:
Start: 09/29/12 End: 01/08/20 Due: 01/08/21

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00607308 Org: User:
Start: 02/29/08 End: 10/31/10 Due: 10/31/11

Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive

Phase: N/A Priority: Normal
NCT ID: NCT03178071 Org: User:
Start: - End: - Due: -

A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Phase: N/A Priority: Normal
NCT ID: NCT00836875 Org: User:
Start: 05/31/09 End: 05/31/13 Due: 05/31/14

A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.

Phase: N/A Priority: Normal
NCT ID: NCT06541678 Org: User:
Start: 12/23/24 End: 06/30/25 Due: 06/30/26

Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)

Phase: N/A Priority: Normal
NCT ID: NCT06613984 Org: User:
Start: 10/11/24 End: 08/29/28 Due: 08/29/29

A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol.

Phase: N/A Priority: Normal
NCT ID: NCT00267254 Org: User:
Start: 01/31/06 End: 08/31/06 Due: 08/31/07

Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00716521 Org: User:
Start: 07/31/08 End: 10/31/08 Due: 10/31/09

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT04743141 Org: User:
Start: 04/28/21 End: 07/31/30 Due: 07/31/31

A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

Phase: N/A Priority: Normal
NCT ID: NCT02493751 Org: User:
Start: 10/26/15 End: 03/04/21 Due: 03/04/22

A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06294925 Org: User:
Start: 05/08/24 End: 05/13/27 Due: 05/13/28

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06629779 Org: User:
Start: 10/22/24 End: 11/30/28 Due: 11/30/29

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Phase: N/A Priority: Normal
NCT ID: NCT06760637 Org: User:
Start: 01/06/25 End: 12/29/37 Due: 12/29/38

SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER

Phase: N/A Priority: Normal
NCT ID: NCT06546800 Org: User:
Start: 05/27/25 End: 02/27/29 Due: 02/27/30

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)

Phase: N/A Priority: Normal
NCT ID: NCT03885037 Org: User:
Start: 03/20/19 End: 11/29/24 Due: 11/29/25